News Releases

November 3, 2022
Corteva Reports Third Quarter and Year-to-Date 2022 Results
Strong Double-Digit Sales Growth Year-to-Date Raises Mid-Point of Full-Year Operating EBITDA 1  Guidance Company Signs Agreement to Acquire Biological Leader Symborg INDIANAPOLIS , Nov. 3, 2022 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) (" Corteva " or the "Company") today reported financial
October 28, 2022
Corteva Declares Quarterly Dividend
INDIANAPOLIS , Oct. 28, 2022 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced its Board of Directors has authorized a common stock dividend of 15 cents per share, payable December 15, 2022 , to the Company's shareholders of record on November 14, 2022 .     E. I.
October 3, 2022
Corteva Announces Dates for Third Quarter 2022 Earnings Release and Webcast
INDIANAPOLIS , Oct. 3, 2022 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced it will release its third quarter 2022 earnings on Thursday, November 3 , after the stock market close via PR Newswire and its website. The Company will host a live webcast of its third quarter 2022 earnings
September 22, 2022
Corteva Agriscience Signs Agreement to Acquire Biological Leader Symborg
Executing on Strategy for Accelerating Vision to Become Biologicals Leader; Delivering Natural Options that Help Farmers Meet Changing Market Expectations INDIANAPOLIS, and MURCIA, Spain, September 22, 2022  — Corteva, Inc. (NYSE: CTVA) and Symborg today announced that Corteva has signed a
September 14, 2022
Corteva Agriscience Showcases Leading R&D Pipeline Advancements
Sustainable innovation fuels Corteva's future product offerings, creating value now and for decades to come for farmers, shareholders and society INDIANAPOLIS , Sept. 14, 2022 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) highlighted its leading pipeline of seed and crop protection innovations focused
September 13, 2022
Corteva Agriscience Announces $2 Billion Share Repurchase Program
Reflects Company's Focus on Returning Capital to Shareholders INDIANAPOLIS , Sept. 13, 2022 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced that its Board of Directors authorized a new $2 billion share repurchase program. The authorization is immediately effective, does not expire, and
September 1, 2022
Corteva Agriscience to Host Investor Day, September 13, 2022
Register for the Virtual Event and Get Updated on Company's Strategy, Innovation and Roadmap for Growth INDIANAPOLIS , Sept. 1, 2022 /PRNewswire/ -- Corteva Agriscience, Inc. (NYSE: CTVA) is hosting an Investor Day on September 13 , 9:00 a.m. to 12 p.m. EDT .
Displaying 1 - 10 of 30

Contact Us

For additional information on Corteva Agriscience:

 302-485-3400

Investor Email Alerts

Search Investor Relations

Safe Harbor Regarding Forward Looking Statements

The information provided herein contains certain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and may be identified by their use of words like “plans,” “expects,” “will,” “anticipates,” “believes,” “intends,” “projects,” “estimates goals” or other words of similar meaning. All statements that address expectations or projections about the future, including statements about Corteva’s strategy for growth, product development, regulatory approval, market position, anticipated benefits of recent acquisitions, timing of anticipated benefits from restructuring actions, outcome of contingencies, such as litigation and environmental matters, expenditures, and financial results, as well as expected benefits from, the separation of Corteva from DowDuPont, are forward-looking statements. Corteva disclaims and does not undertake any obligation to update or revise any forward-looking statement environmental, sustainability, and governance goals or targets or other estimate, except as required by applicable law. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements or other estimates is included in the “Risk Factors” section of Corteva’s Annual Report on Form 10-K, as modified by subsequent reports on Form 10-Q and Current Reports on Form 8-K